![](https://media.gettyimages.com/id/2160633003/ru/%D1%84%D0%BE%D1%82%D0%BE/novo-nordisk-advertising-flags-and-logo-on-facade-building-danish-pharmaceutical-healthcare.jpg?b=1&s=170667a&w=0&k=20&c=Bpatax2kJhOAYJo2Eyw81xijxKbn9lmd-4Rm9f6pYds=)
Novo Nordisk: Better Buying Opportunities Ahead
Victor Golmer/iStock Editorial via Getty Images Investment thesis Novo Nordisk A/S (NVO, OTCPK:NONOF) is the stock market's superstar, having delivered a 20.8% annualized return over the last three decades. The company is the largest European …